Pasithea Therapeutics CFO Stanley Gloss passes away; search for replacement underway

Pasithea Therapeutics Corp.

Stanley Gloss, CFO of Pasithea Therapeutics, passed away on June 7, 2022.
Company has commenced a search for a new Chief Financial Officer.
No other officer or board changes were announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stanley Gloss

Chief Financial Officer

KTTA · Pasithea Therapeutics Corp.

Effective: 2022-06-07
Filed: June 10, 2022, 7:59 PM ET

On June 7, 2022, Stanley Gloss, the Chief Financial Officer of Pasithea Therapeutics Corp. (the “Company”), passed away.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stanley Gloss departed as Chief Financial Officer at Pasithea Therapeutics Corp..

Action: passed away
Role: Chief Financial Officer

Exact text from the filing

On June 7, 2022, Stanley Gloss, the Chief Financial Officer of Pasithea Therapeutics Corp. (the “Company”), passed away.

View on SEC.gov

Pasithea Therapeutics Corp. filing history →

Source: SEC EDGAR

accession 0001213900-22-032102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.